Le Lézard
Classified in: Business
Subject: ECO

Home Price Growth Decelerated in the Third Quarter


FNM-HPI Measured Annual Home Price Growth of 13.8 Percent in Q3 2022

WASHINGTON, Oct. 17, 2022 /PRNewswire/ -- Single-family home prices increased at a non-seasonally adjusted annual rate of 13.8 percent in Q3 2022, down from the previous quarter's revised 19.1 percent, according to Fannie Mae's (OTCQB: FNMA) latest Home Price Index (FNM-HPI) reading, a national, repeat-transaction home price index measuring the average, quarterly price change for all single-family properties in the United States, excluding condos. On a quarterly basis, home prices rose a seasonally adjusted 0.2 percent in Q3 2022, the slowest quarter of growth since Q4 2011. On a non-seasonally adjusted basis, home prices declined by 0.2 percent in Q3 2022.

"Year-over-year home price growth decelerated in the third quarter, as the sharp rise in mortgage rates ? and declining housing affordability ? appears to have weighed further on demand," said Doug Duncan, Fannie Mae Senior Vice President and Chief Economist. "In addition to the greater affordability constraints for potential homebuyers, many existing homeowners likely feel 'locked-in' to their existing, lower interest-rate mortgages. This contributes to fewer homes being listed, as well as fewer potential buyers, and may lead to a growing share of listings having to cut prices to meet the reduced demand. Furthermore, the supply of completed, new single-family homes for sale has begun to rise, suggesting that homebuilders may also need to begin offering greater price concessions to move inventory. We expect these trends to continue in the coming months."

The FNM-HPI is produced by aggregating county-level data to create both seasonally adjusted and non-seasonally adjusted national indices that are representative of the whole country and designed to serve as indicators of general single-family home price trends. The FNM-HPI is publicly available at the national level as a quarterly series with a start date of Q1 1975 and extending to the most recent quarter, Q3 2022. Fannie Mae publishes the FNM-HPI approximately mid-month during the first month of each new quarter.

For more information on the FNM-HPI, including a description of the methodology and the Q3 2022 data file, please visit our Research & Insights page on fanniemae.com.

To receive e-mail updates regarding future FNM-HPI updates and other housing market research from Fannie Mae's Economic & Strategic Research Group, please click here.

Fannie Mae's home price estimates are based on preliminary data available as of the date of index estimation and are subject to change as additional data become available. Opinions, analyses, estimates, forecasts, and other views of Fannie Mae's Economic & Strategic Research (ESR) group included in these materials should not be construed as indicating Fannie Mae's business prospects or expected results, are based on a number of assumptions, and are subject to change without notice. How this information affects Fannie Mae will depend on many factors. Although the ESR group bases its opinions, analyses, estimates, forecasts, and other views on information it considers reliable, it does not guarantee that the information provided in these materials is accurate, current or suitable for any particular purpose. Changes in the assumptions or the information underlying these views could produce materially different results. The analyses, opinions, estimates, forecasts, and other views published by the ESR group represent the views of that group as of the date indicated and do not necessarily represent the views of Fannie Mae or its management.

About the ESR Group
Fannie Mae's Economic and Strategic Research Group, led by Chief Economist Doug Duncan, studies current data, analyzes historical and emerging trends, and conducts surveys of consumer and mortgage lender groups to provide forecasts and analyses on the economy, housing, and mortgage markets. The ESR Group was recently awarded the prestigious 2022 Lawrence R. Klein Award for Blue Chip Forecast Accuracy based on the accuracy of its macroeconomic forecasts published over the 4-year period from 2018 to 2021.

About Fannie Mae
Fannie Mae advances equitable and sustainable access to homeownership and quality, affordable rental housing for millions of people across America. We enable the 30-year fixed-rate mortgage and drive responsible innovation to make homebuying and renting easier, fairer, and more accessible. To learn more, visit:
fanniemae.com | Twitter | Facebook | LinkedIn | Instagram | YouTube | Blog

Fannie Mae Newsroom
https://www.fanniemae.com/news

Photo of Fannie Mae
https://www.fanniemae.com/resources/img/about-fm/fm-building.tif

Fannie Mae Resource Center
1-800-2FANNIE

SOURCE Fannie Mae


These press releases may also interest you

at 04:00
Siemens Digital Industries Software and Daimler Truck AG today announced a new collaboration to implement a state-of-the-art digital engineering platform built using the Siemens...

at 04:00
The total private wealth currently held on the African continent is USD 2.4 trillion and its millionaire population is expected to rise by 42% over the next 10 years, according to the latest 2023 Africa Wealth Report, published by Henley & Partners...

at 03:46
Bluefors, a leading Finnish manufacturer of cryogenic measurement systems, has today announced the completion of its acquisition of Cryomech, a pioneering cryocooler technology and manufacturing company, based in Syracuse, New York, USA. "Joining...

at 03:38
GotPhoto is dedicated to making photographers' lives easier and more efficient. The Company provides an end-to-end workflow and e-commerce solution enabling its customers to digitalize key parts of their workflow, from photo management to payment and...

at 03:36
Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group", HKEx:2318; SSE:601318) has published its 2022 Sustainability Report. The Group's 14th annual sustainability report includes its 3rd report using the international Task Force...

at 03:36
OncoVent Co., Ltd. ("OncoVent"), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agreement with Orient EuroPharma Co., Ltd. ("OEP"). According to the terms of the...



News published on 17 october 2022 at 10:30 and distributed by: